Breaking News
DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
RYTHM Reports Q3 2026 Financial Results
ROLLING MEADOWS – RYTHM, Inc. posted Q3 2026 revenue of ...
GTI Reports Q3 2026 Financial Results
CHICAGO – Green Thumb Industries reported $324.4 million in revenue ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
DEA Bars Dual-Purpose Dispensaries From Federal Medical Cannabis Registration
WASHINGTON – In April, followed by Trump administration's rescheduling order, the U.S. Department of Justice announced that the DEA had granted federal registrations to more than 900 state-licensed medical Cannabis dispensaries in Alabama, Florida, Mississippi, ...
Cannabis Deals Multiply and Shrink in Q3 2026, Viridian Finds
LOS ANGELES – The Viridian Cannabis Deal Tracker counted 74 transactions in the third quarter: 28 in M&A, 27 in equity and 19 in debt. That is the most in any quarter since early 2023 ...
AJNA Biosciences Files for DEA Authorization to Grow Cannabis Under FDA Drug Framework
LITTLETON – AJNA Biosciences, a botanical drug development company, applied to the DEA for registration as a bulk manufacturer of Schedule I controlled substances. The filing, made available for public inspection on 30 October and ...
